TrialJMIR formative research2026

Lucinactant, a Synthetic Surfactant for the Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19: Phase 1/2A Trial.

Yuh-Chin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.